Population-based screening with the coronary heart disease risk factor calculator®

Advances in Therapy

Volumn 18, Issue 1, 2001, Pages 21-32

  Day, D ^a  

^a PFIZER INC   (United States)

Author keywords

Calculator; Coronary heart disease; Risk factor

Indexed keywords

ADULT; ARTICLE; COMPUTER PROGRAM; CONTROLLED STUDY; CORONARY RISK; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; RATING SCALE; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM; SCREENING TEST;

EID: 0035033666     PISSN: 0741238X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02850248     Document Type: Article

References (35)

1. Secular trends in long-term sustained hypertension, long-term treatment, and cardiovascular mortality: The Framingham Heart Study 1950-1990
2. Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations: A statement for healthcare professionals from the American Heart Association and the American College of Cardiology
3. Primary prevention of coronary heart disease: Integrating risk assessment with intervention
4. Prediction of coronary heart disease using risk factor categories
5. Forecasting patient outcomes in the management of hyperlipidemia
6. Serum cholesterol lipoproteins, and the risk of coronary heart disease
7. Rationale for effective treatment of hypercholesterolemia
8. Celebrating 40 years of the Framingham Heart Study
9. The National Cholesterol Education Program
10. Lipid management in a private cardiology practice (the Midwest Heart Experience)
11. Hypertension detection, treatment and control
12. Long-term absolute benefit of lowering blood pressure in hypertensive patients according to the JNC-VI risk stratification
13. Blood pressure, stroke and coronary heart disease, part 1: Prolonged differences in blood pressure: Prospective observational studies corrected for the regression dilution bias
14. Epidemiology of heart failure
15. Blood pressure and end-stage renal disease in men
16. Elevated systolic blood pressure and risk of cardiovascular and renal disease: An overview of evidence from observational epidemiologic studies and randomized controlled trials
17. Cross-clarification of JNC-VI blood pressure stages and risk groups in the Framingham Heart Study
18. Overview of INC-VI: New directions in the management of hypertension of cardiovascular risk
19. Hypertension in elderly patients: Treatment reduces mortality, but is underused
20. The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure
21. An evidence-based assessment of the NCEP Adult Treatment Panel II guidelines
22. Secondary prevention in cardiology group practice and hospital setting after a heart-care initiative
23. Cigarette smoking and coronary heart disease: Risks and management
24. Risk for cardiovascular disease in the elderly and associated Medicare costs: The Framingham Study
25. Changes in risk factors and the decline in mortality from cardiovascular disease: The Framingham Study
26. Mild hypercholesterolemia and premature heart disease: The national criteria underestimate disease risk
27. Association of coronary heart disease risk factors with microscopic qualities of coronary atherosclerosis in youth
28. Cost and benefits of prevention and disease management
29. Primary and subsequent coronary risk appraisal: New results from the Framingham Study
30. Development of health risk appraisal functions in the presence of multiple indicators: The Framingham Study nursing home institutionalization model
31. The relationship between modifiable health risks and health care expenditures
32. Diabetes and cardiovascular disease: A statement for healthcare professionals from the American Heart Association
33. Guide to preventative cardiology for women. AHA/ACC scientific statement: Consensus panel statement
34. An updated coronary risk profile: A statement for health professionals
35. Long-term epidemiologic prediction of coronary disease: The Framingham experience